Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6253) 6253
Book Chapter (85) 85
Magazine Article (16) 16
Conference Proceeding (5) 5
Book / eBook (4) 4
Reference (3) 3
Web Resource (3) 3
Dissertation (1) 1
Newsletter (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
trastuzumab (5560) 5560
humans (5352) 5352
science & technology (4728) 4728
life sciences & biomedicine (4454) 4454
female (4203) 4203
breast neoplasms - drug therapy (3376) 3376
oncology (3217) 3217
breast cancer (2803) 2803
antibodies, monoclonal, humanized (2306) 2306
antineoplastic agents - therapeutic use (2121) 2121
breast neoplasms - pathology (1802) 1802
middle aged (1773) 1773
receptor, erbb-2 - metabolism (1706) 1706
antibodies, monoclonal - therapeutic use (1693) 1693
antineoplastic combined chemotherapy protocols - therapeutic use (1609) 1609
cancer (1438) 1438
adult (1390) 1390
aged (1350) 1350
tumors (1313) 1313
chemotherapy (1166) 1166
breast neoplasms - metabolism (1147) 1147
treatment outcome (1095) 1095
biological and medical sciences (1004) 1004
medical sciences (986) 986
animals (900) 900
her2 (896) 896
skin and connective tissue diseases (880) 880
breast neoplasms - genetics (839) 839
antibodies, monoclonal, humanized - therapeutic use (838) 838
antineoplastic agents (818) 818
metastasis (797) 797
care and treatment (772) 772
receptor, erbb-2 - genetics (771) 771
erbb-2 protein (754) 754
cell line, tumor (717) 717
receptor, erbb-2 - antagonists & inhibitors (712) 712
antibodies, monoclonal - administration & dosage (699) 699
epidermal growth factor (675) 675
medicine & public health (671) 671
prognosis (660) 660
trastuzumab - therapeutic use (637) 637
chemotherapy, adjuvant (621) 621
research (597) 597
cancer therapies (592) 592
gynecology. andrology. obstetrics (567) 567
antibodies, monoclonal, humanized - administration & dosage (565) 565
disease-free survival (563) 563
mice (558) 558
mammary gland diseases (548) 548
drug therapy (543) 543
pharmacology & pharmacy (534) 534
antineoplastic agents - adverse effects (515) 515
breast neoplasms - mortality (514) 514
antineoplastic agents - pharmacology (505) 505
analysis (492) 492
receptor, erbb-2 - analysis (492) 492
neoplasms (488) 488
aged, 80 and over (483) 483
neoplasm metastasis (483) 483
pharmacology. drug treatments (477) 477
male (476) 476
monoclonal antibodies (475) 475
neoplasm staging (470) 470
trastuzumab - administration & dosage (467) 467
immunohistochemistry (451) 451
antineoplastic combined chemotherapy protocols - adverse effects (426) 426
retrospective studies (420) 420
health aspects (419) 419
antimitotic agents (413) 413
patients (406) 406
neoadjuvant therapy (401) 401
clinical trials as topic (395) 395
antibodies, monoclonal - adverse effects (391) 391
clinical trials (391) 391
hematology, oncology and palliative medicine (369) 369
antineoplastic agents - administration & dosage (367) 367
receptor, erbb-2 - immunology (362) 362
paclitaxel - administration & dosage (355) 355
lapatinib (352) 352
taxoids - administration & dosage (349) 349
metastases (345) 345
antibodies, monoclonal - pharmacology (342) 342
drug resistance, neoplasm (338) 338
stomach neoplasms - drug therapy (326) 326
breast neoplasms - therapy (324) 324
proteins (312) 312
quinazolines - therapeutic use (310) 310
cancer research (302) 302
kinases (294) 294
abridged index medicus (292) 292
immunotherapy (290) 290
metastatic breast cancer (289) 289
breast neoplasms - chemistry (285) 285
neoplasms - drug therapy (281) 281
receptor, erbb-2 - biosynthesis (280) 280
research article (279) 279
medical prognosis (275) 275
survival analysis (271) 271
antibodies, monoclonal, humanized - adverse effects (270) 270
breast neoplasms - surgery (270) 270
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5997) 5997
Japanese (225) 225
French (104) 104
German (64) 64
Chinese (51) 51
Russian (25) 25
Portuguese (17) 17
Spanish (17) 17
Hungarian (13) 13
Italian (12) 12
Polish (8) 8
Dutch (7) 7
Czech (6) 6
Norwegian (5) 5
Danish (4) 4
Hebrew (4) 4
Finnish (3) 3
Swedish (3) 3
Serbian (2) 2
Slovak (2) 2
Bulgarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. From single- to multi-target drugs in cancer therapy: When aspecificity becomes an advantage
by Petrelli, Annalisa and Giordano, Silvia
Current medicinal chemistry, ISSN 0929-8673, 02/2008, Volume 15, Issue 5, pp. 422 - 432
Monoclonal antibodies | Small molecules | Tyrosine kinase receptors | Targeted therapy | Cancer therapy | Tyrosine kinase inhibitors | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Erlotinib Hydrochloride | Niacinamide - analogs & derivatives | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Phenylurea Compounds | Bevacizumab | Antibodies, Monoclonal, Humanized | Sunitinib | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Lapatinib | Cetuximab | Gefitinib | Pyrroles - therapeutic use | Pyridines - therapeutic use | Clinical Trials as Topic | Piperazines - therapeutic use | Enzyme Inhibitors - therapeutic use | Imatinib Mesylate | Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neovascularization, Pathologic - drug therapy | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Quinazolines - therapeutic use | Sorafenib | Indoles - therapeutic use | Benzamides | Trastuzumab | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article
Details down arrow
2. Full Text Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
by Schneeweiss, A and Chia, S and Hickish, T and Harvey, V and Eniu, A and Hegg, R and Tausch, C and Seo, J.H and Tsai, Y.-F and Ratnayake, J and McNally, V and Ross, G and Cortés, J
Annals of oncology, ISSN 0923-7534, 09/2013, Volume 24, Issue 9, pp. 2278 - 2284
early breast cancer | trastuzumab | LVSD | neoadjuvant | pertuzumab | HER2 | Neoadjuvant | Pertuzumab | Early breast cancer | Trastuzumab | Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Anthracyclines - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Ventricular Function, Left - drug effects | Docetaxel | Receptor, ErbB-2 - metabolism | Stroke Volume - drug effects | Antineoplastic Agents - therapeutic use | Cyclophosphamide - therapeutic use | Fluorouracil - therapeutic use | Taxoids - therapeutic use | Carboplatin - therapeutic use | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Inflammatory Breast Neoplasms - drug therapy | Neoadjuvant Therapy - methods | Epirubicin - therapeutic use | Heart - drug effects | Female | Receptor, ErbB-2 - antagonists & inhibitors | Anthracyclines - therapeutic use | Inflammatory Breast Neoplasms - surgery | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text New developments for antibody-drug conjugate-based therapeutic approaches
by de Goeij, Bart ECG and Lambert, John M
Current opinion in immunology, ISSN 0952-7915, 2016, Volume 40, pp. 14 - 23
Allergy and Immunology | Life Sciences & Biomedicine | Immunology | Science & Technology | Immunotherapy - methods | Antibodies, Monoclonal, Humanized - therapeutic use | Risk Assessment | Maytansine - analogs & derivatives | Humans | Clinical Protocols | Maytansine - therapeutic use | Neoplasms - therapy | Animals | Immunotoxins - therapeutic use | Neoplasms - immunology | Drug-Related Side Effects and Adverse Reactions | Immunotherapy - trends | Immunoconjugates - therapeutic use | Trastuzumab | Viral antibodies | Antibodies | Electrocardiography | Health aspects | Electrocardiogram | Biopharmaceutics | Antigens | Usage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Immunotherapy of cancer in 2012
by Kirkwood, John M and Butterfield, Lisa H and Tarhini, Ahmad A and Zarour, Hassane and Kalinski, Pawel and Ferrone, Soldano
CA: a cancer journal for clinicians, ISSN 0007-9235, 09/2012, Volume 62, Issue 5, pp. 309 - 335
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunotherapy - methods | Dendritic Cells - immunology | Humans | Dendritic Cells - physiology | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Cancer Vaccines - therapeutic use | Neoplasms - therapy | Immunotherapy - trends | Angiogenesis Inhibitors - therapeutic use | Receptor, ErbB-2 - antagonists & inhibitors | Cetuximab | Yttrium Radioisotopes - therapeutic use | Gene Transfer Techniques | Histocompatibility Antigens - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Vaccines, DNA - therapeutic use | alpha-Fetoproteins - therapeutic use | alpha-Fetoproteins - immunology | Neoplasms - immunology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - antagonists & inhibitors | Receptor, Epidermal Growth Factor - antagonists & inhibitors | T-Lymphocytes - immunology | Genetic Vectors | Trastuzumab | Care and treatment | Usage | Research | Health aspects | Immunotherapy | Cancer | Immunology | Cancer therapies | Manipulation | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights